Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Purchase individual online access for 1 year to this journal.
Price: EUR 595.00Impact Factor 2024: 3.4
The Journal of Alzheimer’s Disease is an international multidisciplinary journal to facilitate progress in understanding the etiology, pathogenesis, epidemiology, genetics, behavior, treatment and psychology of Alzheimer’s disease.
The journal publishes research reports, reviews, short communications, book reviews, and letters-to-the-editor. The journal is dedicated to providing an open forum for original research that will expedite our fundamental understanding of Alzheimer’s disease.
Authors: Belan, Ariella Fornachari Ribeiro | Pais, Marcos Vasconcelos | Camargo, Marina von Zuben de Arruda | Sant’Ana, Livea Carla Fidalgo Garcêz | Radanovic, Marcia | Forlenza, Orestes Vicente
Article Type: Research Article
Abstract: Background: The assessment of language changes associated with visual search impairment can be an important diagnostic tool in the Alzheimer’s disease (AD) continuum. Objective: Investigate the performance of an eye-tracking assisted visual inference language task in differentiating subjects with mild cognitive impairment (MCI) or AD dementia from cognitively unimpaired older adults (controls). Methods: We assessed a group of 95 older adults (49 MCI, 18 mild dementia due to AD, and 28 controls). The subjects performed the same task under multiple experimental conditions which generate correlated responses that need to be taken into account. Thus, we performed …a non-parametric repeated measures ANOVA model for verbal answers, and a linear mixed model (LMM) or its generalized version for the analysis of eye tracking variables. Results: Significant differences were found in verbal answers across all diagnostic groups independently of type of inference, i.e., logic or pragmatic. Also, eye-tracking parameters were able to discriminate AD from MCI and controls. AD patients did more visits to challenge stimulus (Control-AD, –0.622, SE = 0.190, p = 0.004; MCI-AD, –0.514, SE = 0.173, p = 0.011), more visits to the correct response stimulus (Control-AD, –1.363, SE = 0.383, p = 0.002; MCI-AD, –0.946, SE = 0.349, p = 0.022), more fixations on distractors (Control-AD, –4.580, SE = 1.172, p = 0.001; MCI-AD, –2.940, SE = 1.070, p = 0.020), and a longer time to first fixation on the correct response stimulus (Control-AD, –0.622, SE = 0.190, p = 0.004; MCI-AD, –0.514, SE = 0.173, p = 0.011). Conclusion: The analysis of oculomotor behavior along with language assessment protocols may increase the sensitivity for detection of subtle deficits in the MCI-AD continuum, representing an important diagnostic tool. Show more
Keywords: Alzheimer’s disease, cognitive impairment, eye movement, eye-tracking, visual inferences, visual search impairment
DOI: 10.3233/JAD-230250
Citation: Journal of Alzheimer's Disease, vol. 94, no. 3, pp. 1105-1119, 2023
Authors: Kulminski, Alexander M. | Feng, Fan | Loiko, Elena | Nazarian, Alireza | Loika, Yury | Culminskaya, Irina
Article Type: Research Article
Abstract: Background: The lack of efficient preventive interventions against Alzheimer’s disease (AD) calls for identifying efficient modifiable risk factors for AD. As diabetes shares many pathological processes with AD, including accumulation of amyloid plaques and neurofibrillary tangles, insulin resistance, and impaired glucose metabolism, diabetes is thought to be a potentially modifiable risk factor for AD. Mounting evidence suggests that links between AD and diabetes may be more complex than previously believed. Objective: To examine the pleiotropic architecture of AD and diabetes mellitus (DM). Methods: Univariate and pleiotropic analyses were performed following the discovery-replication strategy using individual-level data …from 10 large-scale studies. Results: We report a potentially novel pleiotropic NOTCH2 gene, with a minor allele of rs5025718 associated with increased risks of both AD and DM. We confirm previously identified antagonistic associations of the same variants with the risks of AD and DM in the HLA and APOE gene clusters. We show multiple antagonistic associations of the same variants with AD and DM in the HLA cluster, which were not explained by the lead SNP in this cluster. Although the ɛ 2 and ɛ 4 alleles played a major role in the antagonistic associations with AD and DM in the APOE cluster, we identified non-overlapping SNPs in this cluster, which were adversely and beneficially associated with AD and DM independently of the ɛ 2 and ɛ 4 alleles. Conclusion: This study emphasizes differences and similarities in the heterogeneous genetic architectures of AD and DM, which may differentiate the pathogenic mechanisms of these diseases. Show more
Keywords: Alzheimer’s disease, apolipoprotein E gene, diabetes, major histocompatibility complex, pleiotropy
DOI: 10.3233/JAD-230397
Citation: Journal of Alzheimer's Disease, vol. 94, no. 3, pp. 1121-1132, 2023
Authors: Jeong, Seong Ho | Cha, Jungho | Jung, Jin Ho | Yun, Mijin | Sohn, Young H. | Chung, Seok Jong | Lee, Phil Hyu
Article Type: Research Article
Abstract: Background: Clinical significance of additional occipital amyloid-β (Aβ) plaques in Alzheimer’s disease (AD) remains unclear. Objective: In this study, we investigated the effect of regional Aβ deposition on cognition in patients on the AD continuum, especially in the occipital region. Methods: We retrospectively reviewed the medical record of 208 patients with AD across the cognitive continuum (non-dementia and dementia). Multivariable linear regression analyses were performed to determine the effect of regional Aβ deposition on cognitive function. A linear mixed model was used to assess the effect of regional deposition on longitudinal changes in Mini-Mental State Examination …(MMSE) scores. Additionally, the patients were dichotomized according to the occipital-to-global Aβ deposition ratio (ratio ≤1, Aβ-OCC– group; ratio >1, Aβ-OCC+ group), and the same statistical analyses were applied for between-group comparisons. Results: Regional Aβ burden itself was not associated with baseline cognitive function. In terms of Aβ-OCC group effect, the Aβ-OCC+ group exhibited a poorer cognitive performance on language function compared to the Aβ-OCC– group. High Aβ retention in each region was associated with a rapid decline in MMSE scores, only in the dementia subgroup. Additionally, Aβ-OCC+ individuals exhibited a faster annual decline in MMSE scores than Aβ-OCC– individuals in the non-dementia subgroup (β= –0.77, standard error [SE] = 0.31, p = 0.013). Conclusion: The present study demonstrated that additional occipital Aβ deposition was associated with poor baseline language function and rapid cognitive deterioration in patients on the AD continuum. Show more
Keywords: Alzheimer’s disease, amyloid, cognition, occipital lobe, prognosis
DOI: 10.3233/JAD-230187
Citation: Journal of Alzheimer's Disease, vol. 94, no. 3, pp. 1133-1144, 2023
Authors: Mobasheri, Kamelia | Zaefizadeh, Mohammad | Ghobeh, Maryam | Eidi, Akram
Article Type: Research Article
Abstract: Background: Alzheimer’s disease (AD) is the most common type of dementia. The drugs introduced for this disease have many side effects and limitations in use, so the production of a suitable herbal medicine to cure AD patients is essential. Objective: The aim of this research is to make a magnetic neuropeptide nano shuttle as a targeted carrier for the transfer of quercetin to the brains of AD model rats. Methods: In this work, a magnetic quercetin-neuropeptide nanocomposite (MQNPN) was fabricated and administered to the rat’s brain by the shuttle drug of the Margatoxin scorpion venom neuropeptide, …and will be a prospect for targeted drug delivery in AD. The MQNPN has been characterized by FTIR, spectroscopy, FE-SEM, XRD, and VSM. Investigations into the efficacy of MQNPN, MTT, and real Time PCR for MAPT and APP genes expression were performed. After 7 days treatment with Fe3 O4 (Ctr) and MQNPN treatment in AD rat, superoxide dismutase activity and quercetin in blood serum and brain was detected. Hematoxylin-Eosin staining was applied for histopathological analysis. Results: Analysis of data showed that MQNPN increased the activity of superoxide dismutase. The histopathology results of the hippocampal region of AD rats also confirmed their improvement after treatment with MQNPN. MQNPN treatment caused a significant decrease in the relative expression of MAPT and APP genes. Conclusion: MQNPN is a suitable carrier for the transfer of quercetin to the rat hippocampus, and has a significant effect in reducing AD symptoms in terms of histopathology, behavioral testing, and changing the expression of AD-related genes. Show more
Keywords: Alzheimer’s disease, nano-drug shuttle system, nanocomposite, neuropeptide, quercetin
DOI: 10.3233/JAD-221095
Citation: Journal of Alzheimer's Disease, vol. 94, no. 3, pp. 1145-1155, 2023
Authors: Araujo-Menendez, Carlos E.E. | Saelzler, Ursula G. | Stickel, Ariana M. | Sundermann, Erin E. | Banks, Sarah J. | Paipilla, Andrea | Barnes, McKinna L. | Panizzon, Matthew S.
Article Type: Research Article
Abstract: Background: Race/ethnicity is associated with differences in reproductive history and cognition individually, yet it remains an understudied factor in the relationship between parity and later-life cognition. Objective: To evaluate if the association between parity and cognition differs between racial/ethnic groups. Methods: Participants included 778 older, postmenopausal women from the Health and Nutrition Examination Survey (Latina: n = 178, Non-Latino Black [NLB]: n = 169, Non-Latino White [NLW]: n = 431) who self-reported at least one birth. Cognitive outcomes included working memory, learning memory, and verbal fluency. Covariates included age, education, cardiovascular and other reproductive health factors, adult socioeconomic status …(SES) and depressive symptoms. We fit a series of linear models to examine a) whether parity was associated with cognitive functioning, b) if this association varied by race/ethnicity through parity by race/ethnicity interactions, and c) individual parity with cognition associations stratified by race/ethnicity. Results: In the full sample, parity was significantly negatively associated with Digit Symbol Substitution Test (DSST) performance (b = –0.70, p = 0.024) but not Animal Fluency or word-list learning and memory. Tests of race/ethnicity-by-parity interactions were not statistically significant (ps > 0.05). However, stratified analyses by race/ethnicity showed a differential effect of parity on DSST performance, such that parity was significantly negatively associated with DSST performance (b = –1.66, p = 0.007) among Latinas but not in NLWs (b = –0.16, p = 0.74) or NLBs (b = –0.81, p = 0.191). Conclusion: Among Latina, but not NLB or NLW women, greater parity was associated with worse processing speed/executive functioning later in life. Further research is needed to understand the mechanisms driving racial/ethnic differences. Show more
Keywords: Alzheimer’s disease, cognition, cross-cultural research, pregnancy, reproductive health
DOI: 10.3233/JAD-221210
Citation: Journal of Alzheimer's Disease, vol. 94, no. 3, pp. 1157-1168, 2023
Authors: Audronyte, Egle | Pakulaite-Kazliene, Gyte | Sutnikiene, Vaiva | Kaubrys, Gintaras
Article Type: Research Article
Abstract: Background: Olfactory dysfunction is an early symptom of Alzheimer’s disease (AD). However, olfactory tests are rarely performed in clinical practice because their diagnostic efficacy in detecting early AD is unclear. Objective: To investigate odor discrimination in patients with early AD and the efficacy of olfactory discrimination tests in differentiating these patients from subjects with normal cognition (CN). Methods: Thirty patients each with mild dementia due to AD (MD-AD) and mild cognitive impairment due to AD (MCI-AD) and 30 older subjects with CN were enrolled. All participants underwent cognitive examinations (CDR, MMSE, ADAS-Cog 13, and verbal fluency) …and odor discrimination tests (Sniffin’ Sticks test, Burghart®, Germany). Results: The MD-AD group achieved significantly worse scores on the olfactory discrimination test than the MCI-AD group, and the MCI-AD group achieved significantly worse results than the CN group (p < 0.05). A cut-off score of≤10 had a diagnostic accuracy of 94.44% (95% CI, 87.51–98.17%) in differentiating patients with MCI-AD/MD-AD from subjects with CN and of 91.67% (95% CI, 81.61–97.24%) in differentiating those with MCI-AD from subjects with CN. Our multinomial logistic regression model with demographic data and ADAS-Cog 13 scores as predictor variables correctly classified 82.2% of the cases (CN, 93.3%; MC-AD, 70%; MD-AD, 83.3%); on adding the olfactory discrimination score to the model, the percentage increased to 92.2% (CN, 96.7%; MCI-AD, 86.7%; MD-AD, 93.3%). Conclusion: Odor discrimination is impaired in cases of early AD and continues to deteriorate as the disease progresses. The olfactory discrimination test showed good diagnostic efficacy in detecting early AD. Show more
Keywords: Alzheimer’s disease, mild cognitive impairment, olfaction, olfactory impairment
DOI: 10.3233/JAD-230077
Citation: Journal of Alzheimer's Disease, vol. 94, no. 3, pp. 1169-1178, 2023
Authors: Alves, Suélen Santos | de Oliveira, José Antônio Cortes | Lazarini-Lopes, Willian | Servilha-Menezes, Gabriel | Grigório-de-Sant’Ana, Mariana | Del Vecchio, Flavio | Mazzei, Rodrigo Focosi | Sousa Almeida, Sebastião | da Silva Junior, Rui Milton Patrício | Garcia-Cairasco, Norberto
Article Type: Research Article
Abstract: Background: Alzheimer’s disease (AD) is a neurodegenerative and progressive disorder with no cure and constant failures in clinical trials. The main AD hallmarks are amyloid-β (Aβ) plaques, neurofibrillary tangles, and neurodegeneration. However, many other events have been implicated in AD pathogenesis. Epilepsy is a common comorbidity of AD and there is important evidence indicating a bidirectional link between these two disorders. Some studies suggest that disturbed insulin signaling might play an important role in this connection. Objective: To understand the effects of neuronal insulin resistance in the AD-epilepsy link. Methods: We submitted the streptozotocin (STZ) induced …rat AD Model (icv-STZ AD) to an acute acoustic stimulus (AS), a known trigger of seizures. We also assessed animals’ performance in the memory test, the Morris water maze and the neuronal activity (c-Fos protein) induced by a single audiogenic seizure in regions that express high levels of insulin receptors. Results: We identified significant memory impairment and seizures in 71.43% of all icv-STZ/AS rats, in contrast to 22.22% of the vehicle group. After seizures, icv-STZ/AS rats presented higher number of c-Fos immunopositive cells in hippocampal, cortical, and hypothalamic regions. Conclusion: STZ may facilitate seizure generation and propagation by impairment of neuronal function, especially in regions that express high levels of insulin receptors. The data presented here indicate that the icv-STZ AD model might have implications not only for AD, but also for epilepsy. Finally, impaired insulin signaling might be one of the mechanisms by which AD presents a bidirectional connection to epilepsy. Show more
Keywords: Acoustic stimulus, Alzheimer’s disease, epilepsy, insulin resistance, memory, seizures, streptozotocin
DOI: 10.3233/JAD-230153
Citation: Journal of Alzheimer's Disease, vol. 94, no. 3, pp. 1179-1196, 2023
Authors: Castelblanco-Toro, Sandra Milena | Jurado-Delgado, Janeth | Meneses-Bernal, Juan Felipe | Santacruz-Escudero, José Manuel | Santamaria-García, Hernando
Article Type: Research Article
Abstract: Background: Fear of falling (FoF) is a condition associated with falls, multi-morbidity, and functional impairment. To date it remains unknow which clinical, somatic, socio-demographic, behavioral, and emotional factors are associated with FoF and how these factors interact in people with Alzheimer’s disease (AD) and behavioral variant frontotemporal dementia (bvFTD). Objective: Identify the association of FoF with clinical, socio-demographic, and neuropsychiatric factors in patients with AD and bvFTD. Methods: We evaluated 98 participants, 58 with AD and 40 with bvFTD at mild or moderate stages and assess FoF using the Falls Efficacy Scale-International. Additionally, we analyzed cognitive, …physical performance variables, functional impairment, and affective and behavioral symptoms associated with FoF using standardized scales and a regression model analysis. Results: The prevalence of FoF in AD and bvFTD was 51% and 40%, respectively. In the AD group, physical performance [F (3, 53) = 4.318, p = 0.009], the behavioral symptoms model [F (19, 38) = 3.314, p = 0.001], and the anxiety model [F (1, 56) = 13.4, p ≤0.01] showed statistically significant values. In addition, the presence of hallucinations assessed with the Neuropsychiatric Inventory and social behavior assessed with the Mild Behavioral Impairment Checklist were significant. In contrast, in the bvFTD group, a homologous group of models was evaluated but we did not find any significant results. Conclusion: FoF in people with AD was related to physical performance, neuropsychiatric symptoms such as apathy and hallucinations, and affective symptoms such as anxiety. However, this pattern was not seen in the bvFTD group, and therefore further studies are required. Show more
Keywords: Alzheimer’s disease, behavioral symptoms, fear of falling, frontotemporal dementia, physical performance
DOI: 10.3233/JAD-230266
Citation: Journal of Alzheimer's Disease, vol. 94, no. 3, pp. 1197-1207, 2023
Authors: Zhang, Jie | Gao, Shang | Liu, Wei
Article Type: Research Article
Abstract: Background: There is a close association between Alzheimer’s disease (AD) and circadian rhythms, and neuroinflammatory-related pathways are associated with both interactions. Objective: To reveal the relationship between circadian rhythm (CR) and AD at the level of genes, pathways, and molecular functions through bioinformatics. Methods: We analyzed the differential genes between AD and control groups in GSE122063 and found the important gene modules; obtained CR-related genes from GeenCard database; used Venn 2.1 database to obtain the intersection of genes of AD important modules with CR-related genes; and used STRING database and Cytoscape 3.7.1 to construct the gene …protein-protein interaction network. The MCODE plugin was used to screen pivotal genes and analyze their differential expression. We trranslated with www.DeepL.com/Translator (free version) to obtain transcriptional regulatory relationships from the TRRUST database and construct a hub gene-transcription factor relationship network. Results: A total of 42 common genes were screened from AD and CR genes, mainly involving signaling pathways such as neuroactive ligand-receptor interactions. A total of 10 pivotal genes were screened from the common genes of CR and AD, which were statistically significant in the comparison of AD and control groups (p < 0.001), and ROC analysis showed that all these pivotal genes had good diagnostic significance. A total of 36 TFs of pivotal genes were obtained. Conclusion: We identified AD- and CR-related signaling pathways and 10 hub genes and found strong associations between these related genes and biological processes such as inflammation. Show more
Keywords: Alzheimer’s disease, bioinformatics, circadian rhythm, hub genes
DOI: 10.3233/JAD-230177
Citation: Journal of Alzheimer's Disease, vol. 94, no. 3, pp. 1209-1224, 2023
Authors: Sorrentino, Federica | Fenoglio, Chiara | Sacchi, Luca | Serpente, Maria | Arighi, Andrea | Carandini, Tiziana | Arosio, Beatrice | Ferri, Evelyn | Arcaro, Marina | Visconte, Caterina | Rotondo, Emanuela | Scarpini, Elio | Galimberti, Daniela
Article Type: Research Article
Abstract: Background: The longevity gene Klotho (KL ) was recently associated with neurodegenerative diseases including Alzheimer’s disease (AD). Its role in the brain has not been completely elucidated, although evidence suggests that KL-VS heterozygosity is associated with a reduced risk of AD in Apolipoprotein E ɛ 4 carriers. Conversely, no data about genetic association with frontotemporal dementia (FTD) are available so far. Objective: To investigate the involvement of KL in AD and FTD by the determination of the genetic frequency of KL-VS variant and the expression analysis of KL gene. Methods: A population consisting …of 438 patients and 240 age-matched controls was enrolled for the study. KL-VS and APOE genotypes were assessed by allelic discrimination through a QuantStudio 12K system. KL gene expression analysis was performed in a restricted cohort of patients consisting of 43 AD patients, 41 FTD patients and 19 controls. KL gene expression was assessed in peripheral blood mononuclear cells with specific TaqMan assay. Statistical analysis was performed using GraphPad 9 Prims software. Results: KL-VS frequency was comparable to the ones found in literature and no differences were found in both allelic and genotypic frequencies between patients and controls were found. Conversely, KL expression levels were significantly lower in AD and FTD patients compared with controls (mean fold regulation – 4.286 and – 6.561 versus controls in AD and FTD, respectively, p = 0.0037). Conclusion: This is the first study investigating KL in FTD. We showed a decreased expression of the gene in AD and FTD, independent of the genotype, suggesting a role of Klotho in common steps during neurodegeneration. Show more
Keywords: Alzheimer’s disease, expression, frontotemporal dementia, Klotho, neurodegeneration
DOI: 10.3233/JAD-230322
Citation: Journal of Alzheimer's Disease, vol. 94, no. 3, pp. 1225-1231, 2023
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]